ID: ALA3425830

Max Phase: Preclinical

Molecular Formula: C21H27FN2O3

Molecular Weight: 374.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(c1ccc(OCC(C)C[18F])c(C(C)C)c1)c1ccc(C(=O)O)cn1

Standard InChI:  InChI=1S/C21H27FN2O3/c1-5-24(20-9-6-16(12-23-20)21(25)26)17-7-8-19(18(10-17)14(2)3)27-13-15(4)11-22/h6-10,12,14-15H,5,11,13H2,1-4H3,(H,25,26)/i22-1

Standard InChI Key:  GZUNYNSCGWSKRA-KVTPGWOSSA-N

Associated Targets(non-human)

Kidney 1278 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Stomach 551 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 8163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Duodenum 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Heart 1016 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 374.46Molecular Weight (Monoisotopic): 374.2006AlogP: 5.05#Rotatable Bonds: 9
Polar Surface Area: 62.66Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.91CX Basic pKa: 4.41CX LogP: 4.11CX LogD: 1.61
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -0.75

References

1. Kobayashi T, Furusawa Y, Yamada S, Akehi M, Takenaka F, Sasaki T, Akahoshi A, Hanada T, Matsuura E, Hirano H, Tai A, Kakuta H..  (2015)  Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists.,  (3): [PMID:25815156] [10.1021/ml500511m]

Source